PRESS RELEASE published on 08/08/2024 at 10:00, 1 year 10 months ago SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers SphingoTec secures €5M Series C funding led by Think.Health Ventures to drive global expansion and commercialize innovative biomarkers for critical care, aiming for improved patient outcomes Funding Biomarkers SphingoTec Critical Care Series C
BRIEF published on 06/18/2024 at 10:05, 2 years ago SphingoTec Introduces PenKid at AKI & CRRT Course in Vicenza SphingoTec Biomarker AKI Kidney Function PenKid
BRIEF published on 06/18/2024 at 10:05, 2 years ago SphingoTec présente PenKid au cours AKI & CRRT à Vicence SphingoTec Biomarqueur AKI Fonction Rénale StyloKid
PRESS RELEASE published on 06/18/2024 at 10:00, 2 years ago Advancing Kidney Care With Solidified Evidence – SphingoTec Presents PenKid at AKI & CRRT Course in Vicenza SphingoTec introduces kidney function biomarker PenKid at AKI & CRRT Course. PenKid addresses AKI diagnostic gaps with real-time assessment and risk prediction capabilities SphingoTec PenKid Kidney Function Biomarker AKI & CRRT Course Biomarker Integration
BRIEF published on 03/26/2024 at 13:05, 2 years 3 months ago SphingoTec annonce des changements majeurs dans sa direction Biomarqueurs Innovations Diagnostiques Changements De Gestion SphingoTec Soin Critique
BRIEF published on 03/26/2024 at 13:05, 2 years 3 months ago SphingoTec Announces Major Management Changes Biomarkers Management Changes Diagnostic Innovations SphingoTec Critical Care
PRESS RELEASE published on 03/26/2024 at 13:00, 2 years 3 months ago SphingoTec Announces Management Changes SphingoTec announces changes in management team with new appointments. Deborah Bergmann appointed as CEO. Dr. Florian Uhle as CMO and Nicole Witzmann as CFO. Company aims to enhance critical care diagnostics Management Team Biomarkers SphingoTec Deborah Bergmann Critical Care Diagnostics
PRESS RELEASE published on 10/05/2023 at 10:00, 2 years 8 months ago New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients
PRESS RELEASE published on 09/06/2023 at 10:00, 2 years 9 months ago International Experts Highlight Demand for Diagnostic Innovations as PenKid's Research and Real-World Data Fuels Quest for Improved RRT Liberation Tools
PRESS RELEASE published on 08/31/2023 at 12:30, 2 years 9 months ago Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
Published on 06/27/2026 at 16:50, 18 hours 40 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 9 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 11 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 12 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 12 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 1 day 11 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 11 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 11 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 11 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 1 day 12 hours ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
